APA (7th ed.) Citation

P, L., J, H., EC, B., A, L., AH, M., L, T., . . . A, Q. (2016). Loss of membranous VEGFR1 expression is associated with an adverse phenotype and shortened survival in breast cancer. Molecular medicine reports, 14(2), 1443. https://doi.org/10.3892/mmr.2016.5430

Chicago Style (17th ed.) Citation

P, Lebok, et al. "Loss of Membranous VEGFR1 Expression Is Associated with an Adverse Phenotype and Shortened Survival in Breast Cancer." Molecular Medicine Reports 14, no. 2 (2016): 1443. https://doi.org/10.3892/mmr.2016.5430.

MLA (9th ed.) Citation

P, Lebok, et al. "Loss of Membranous VEGFR1 Expression Is Associated with an Adverse Phenotype and Shortened Survival in Breast Cancer." Molecular Medicine Reports, vol. 14, no. 2, 2016, p. 1443, https://doi.org/10.3892/mmr.2016.5430.